Overall Survival and Health Care Costs of Medicare Patients with Previously Treated Chronic Lymphocytic Leukemia

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations

"Overall Survival and Health Care Costs of Medicare Patients with Previously Treated Chronic Lymphocytic Leukemia"
written by Carolina Reyes, Genevieve Gauthier, Sherry Shi, Annie Guerin,
published by Journal of Cancer Therapy, Vol.9 No.7, 2018

has been cited by the following article(s):

[1]	Treatment Patterns, Healthcare Resource Utilization, and Costs of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the US
	The …, 2024

[2]	Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-Cell lymphoma
	Journal of Medical …, 2024

[3]	Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the …
	2021

[1]	Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma Journal of Medical Economics, 2024 DOI:10.1080/13696998.2024.2349472

[2]	Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population Cancer Medicine, 2021 DOI:10.1002/cam4.3855

[3]	Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population Cancer Medicine, 2021 DOI:10.1002/cam4.3855

Follow SCIRP